Japanese Company Says Ivermectin Shows ‘Antiviral Effect’ Against COVID-19

Japanese trading and pharmaceuticals company Kowa announced that Ivermectin has shown an “antiviral effect” against COVID-19 in joint non-clinical research.

“The company, which has been working with Tokyo’s Kitasato University on testing the drug as a potential treatment for COVID-19, did not provide further details,” Reuters reported Monday.

“The use of ivermectin to treat COVID-19 is currently being investigated in a UK trial run by the University of Oxford,” the report added. “The researchers said on Monday that it was still under way and they did not want to comment further until they have results to report.”

STORY CONTINUED ON DAILY WIRE